Dr. Nazario is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1411 N Beckley Ave
Ste 268
Dallas, TX 75203Phone+1 214-947-4400
Education & Training
Baylor University Medical CenterFellowship, Transplant Hepatology, 2010 - 2011
University of Texas Southwestern Medical CenterFellowship, Gastroenterology, 2007 - 2010
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 2002 - 2005
University of Puerto Rico School of MedicineClass of 2002
Certifications & Licensure
IL State Medical License 2024 - 2026
PR State Medical License 2024 - 2026
CO State Medical License 2024 - 2025
TX State Medical License 2005 - 2024- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Publications & Presentations
PubMed
- 92 citationsSofosbuvir and simeprevir in hepatitis C genotype 1-patients with end-stage renal disease on haemodialysis or GFR <30 ml/minHector E. Nazario, Milka Ndungu, A.A. Modi
Liver International. 2016-06-01 - 26 citationsMetastatic breast cancer presenting as acute liver failure.Hector E Nazario, Rita Lepe, James F. Trotter
Gastroenterology & Hepatology. 2011-01-01 - 28 citationsSafety and efficacy of simeprevir plus sofosbuvir with or without ribavirin in patients with decompensated genotype 1 hepatitis C cirrhosisA.A. Modi, Hector E. Nazario, James F. Trotter, Manjushree Gautam, Jeffrey L. Weinstein
Liver Transplantation. 2016-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
